Overexpression of HER3 was identified in various malignant tumor types, such as breast, gastric, colorectal, prostate, lung, ovarian, and pancreatic cancers [17,18,19,20,21,22]. This evidence concerns the gene ERBB3 and familial pancreatic carcinoma.